Propanc Biopharma, Inc. (PPCB) Ownership
PPCB ownership summary
as of October 18, 2026- Institutions
- 0.8% of shares outstanding
- Insiders
- 62.20% of shares outstanding
- Shares outstanding
- 9.8M
- Float
- 5.4M shares available to trade
- Short interest
- 1.30% 71K shares short
- Days to cover
- 0.21 short interest up 145.4% vs prior month
- Institutions 0.76%
- Insiders 62.20%
- Other investors 37.04%
PPCB top institutional holders
12 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Jane Street Group LLC | 0.40% | 26K | $8,738 | +25,550 (0.0%) | June 30, 2026 |
| 2 | Citadel Advisors Llc | 0.19% | 12K | $4,135 | +12,090 (0.0%) | June 30, 2026 |
| 3 | HRT FINANCIAL LLC | 0.16% | 10K | $3,503 | +10,242 (0.0%) | June 30, 2026 |
| 4 | Caitong International Asset Management Co., Limited. | 0.00% | 2 | $1 | +2 (0.0%) | June 30, 2026 |
| 5 | Mercer Global Advisors Inc. | 0.00% | 1 | $0 | +1 (0.0%) | June 30, 2026 |
| 6 | Morgan Stanley - Brokerage Accounts | 0.00% | — | — | −2 (−100.0%) | March 31, 2026 |
| 7 | Sassicaia Capital Advisers LLC | 0.00% | — | — | −640 (−100.0%) | June 30, 2026 |
| 8 | Two Sigma Investments LLC | 0.00% | — | — | −16,257 (−100.0%) | March 31, 2026 |
| 9 | XTX Topco Ltd | 0.00% | — | — | −484 (−100.0%) | June 30, 2026 |
| 10 | TWO SIGMA SECURITIES, LLC | 0.00% | — | — | −25,483 (−100.0%) | March 31, 2026 |
| 11 | Marex Group Ltd | 0.00% | — | — | −2,709 (−100.0%) | June 30, 2026 |
| 12 | UBS Group AG | 0.00% | — | — | −7,305 (−100.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 12, 5 holders added 48K shares and 7 cut 53K.
PPCB shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns PPCB
Institutional investors own 0.8% of Propanc Biopharma's shares and insiders 62.20%. The largest holder is Jane Street Group LLC with 0.40% of the shares (26K), as of June 30, 2026. Among the top 12 institutions, 5 added shares and 7 reduced their stake in the latest filings. Short interest is 1.30% of the float, or 0.21 days of average trading volume. The share count rose 59,277.8% since 2020.
Related: PPCB key metrics. See the PPCB stock overview for the latest quote and news.
PPCB ownership FAQ
Who owns the most Propanc Biopharma stock?
The largest shareholders of Propanc Biopharma are Jane Street Group LLC (0.40%), Citadel Advisors Llc (0.19%), HRT FINANCIAL LLC (0.16%), Caitong International Asset Management Co., Limited. (0.00%), Mercer Global Advisors Inc. (0.00%).
What percentage of Propanc Biopharma is owned by institutions?
Institutions hold 0.8% of Propanc Biopharma's shares outstanding; insiders hold 62.20%.
What is Propanc Biopharma's short interest?
71K shares of Propanc Biopharma were sold short, 1.30% of the float; at the average daily volume it would take 0.21 days to cover.
How many shares of Propanc Biopharma are outstanding?
Propanc Biopharma has 9.8M shares outstanding, of which 5.4M are in the public float.